Results 311 to 320 of about 203,049 (341)
Some of the next articles are maybe not open access.
Update on ventricular assist devices
Current Opinion in Anaesthesiology, 2010Over the past two decades, medicine has seen a robust increase in the use of ventricular assist devices. The purpose of this review is to update the information concerning these devices, their advantages and disadvantages as well as their complications.
Rosanne Sheinberg, Nanhi Mitter
openaire +3 more sources
Evolution of Left Ventricular Assist Device Therapy for Advanced Heart Failure: A Review
JAMA cardiology, 2018Importance The mortality rate for the most advanced forms of heart failure with medical therapy alone remains unacceptably high at 30% to 80% at 1 year.
L. Miller, J. Rogers
semanticscholar +1 more source
Left ventricular assist devices [PDF]
Heart, 2009 Left ventricular assist device (LVAD) insertion in patients with advanced heart failure with deteriorating clinical status is life saving, and LVADs are now being inserted into an increasing number of patients with advanced heart failure. They were initially inserted as a bridge to transplantation, and the decreased availability of donor hearts means ...
openaire +2 more sources
European Journal of Cardio-Thoracic Surgery, 2019
Left ventricular assist device-associated infections represent a major complication during long-term support. Driveline exit site infections harbour the risk of ascending into the pump, causing deep-seated infections.
J. Mulzer, A. Trampuz, E. Potapov
semanticscholar +1 more source
Left ventricular assist device-associated infections represent a major complication during long-term support. Driveline exit site infections harbour the risk of ascending into the pump, causing deep-seated infections.
J. Mulzer, A. Trampuz, E. Potapov
semanticscholar +1 more source
Minimally Invasive Left Ventricular Assist Device Implantation: A Comparative Study
Artificial Organs, 2018Left ventricular assist device (LVAD) is now a routine therapy for advanced heart failure. Minimally invasive approach via thoracotomy for LVAD implantation is getting popular due to its potential advantage over the conventional sternotomy approach in ...
P. Mohite +14 more
semanticscholar +1 more source
Pediatric Transplantation, 2019
This study's objective was to investigate compassionate ventricular assist device deactivation (VADdeact) in children from the perspective of the pediatric heart failure provider.
B. Kaufman +11 more
semanticscholar +1 more source
This study's objective was to investigate compassionate ventricular assist device deactivation (VADdeact) in children from the perspective of the pediatric heart failure provider.
B. Kaufman +11 more
semanticscholar +1 more source
Pediatric Ventricular Assist Devices
Pediatric Cardiology, 2007Ventricular assist device therapy is continuing to evolve in the practice of pediatric cardiac surgery. Although ECMO is still the most often applied mechanical support for infants and young children, a broader range of pulsatile, paracorporeal, as well as implantable ventricular assist devices are now available for pediatric application.
Christopher S. Almond +1 more
openaire +3 more sources
2020
End-stage heart disease can be a result of idiopathic cardiomyopathy, chronic ischemic damage or long-standing volume or pressure overload from valvular pathology. While cardiac transplantation may be the ultimate therapy for the fortunate patient who is eligible, the number of available organs is outweighed by the far larger number of patients who ...
openaire +2 more sources
End-stage heart disease can be a result of idiopathic cardiomyopathy, chronic ischemic damage or long-standing volume or pressure overload from valvular pathology. While cardiac transplantation may be the ultimate therapy for the fortunate patient who is eligible, the number of available organs is outweighed by the far larger number of patients who ...
openaire +2 more sources
Update on Ventricular Assist Devices
AACN Advanced Critical Care, 1990Ventricular assist devices serve as a valuable adjunct to therapy in the setting of profound heart failure. The two largest patient groups—postcardiotomy and those being bridged to transplant—show an average 40–50% survival rate after ventricular assist. Several devices exist including centrifugal, pneumatic, and electrical pumps.
Rosemary Lee, Connie Barden
openaire +3 more sources
Ventricular Assist Devices and Anesthesia
Seminars in Cardiothoracic and Vascular Anesthesia, 2005Ventricular assist devices (VADs) have revolutionized longterm care for patients with congestive heart failure. These patients represent about 1% of the adults in the United States, considering that heart failure is a contributing factor in more than 250,000 deaths annually.
openaire +3 more sources